Q2 2020 Holdings
Filed 2020-08-14 | 134 holdings | $826.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $160.1M | 850,000 | 19.4% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $133.5M | 2,000,000 | 16.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $133.3M | 900,000 | 16.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $101.4M | 450,000 | 12.3% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $80.3M | 372,500 | 9.7% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $65.2M | 1,546,517 | 7.9% |
| Avantor Inc(AVTR) | COM | 05352A100 | $34.0M | 2,000,000 | 4.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $20.1M | 376,000 | 2.4% |
| American Airls Group Inc(AAL) | COM | 02376R102 | $19.6M | 1,500,000 | 2.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $19.6M | 600,000 | 2.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $14.6M | 900,000 | 1.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $9.6M | 65,000 | 1.2% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $9.1M | 188,000 | 1.1% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $7.8M | 574,000 | 0.9% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $6.4M | 400,000 | 0.8% |
| Alector Inc(ALEC) | COM | 014442107 | $4.9M | 200,000 | 0.6% |
| Cryoport Inc(CYRX) | COM PAR $0.001 | 229050307 | $2.7M | 89,000 | 0.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.6M | 188,000 | 0.2% |
| WW Intl Inc(WW6) | COM | 98262P101 | $376.1K | 14,818,300 | 0.0% |
| JPMorgan Chase & Co(JPM)Call | COM | 46625H100 | $282.2K | 3,000,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $133.4K | 1,400,000 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $120.2K | 60,240,864 | 0.0% |
| GDS Hldgs LTD(GDS) | SPONSORED ADS | 36165L108 | $87.6K | 1,100,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $82.2K | 897,445 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $61.8K | 1,800,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $59.1K | 2,814,191 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $56.1K | 500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $52.8K | 3,500,000 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $51.1K | 1,000,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $46.0K | 2,524,040 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $45.2K | 1,669,186 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $45.1K | 1,000,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $42.9K | 550,000 | 0.0% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $39.5K | 200,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $38.8K | 650,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $36.4K | 2,500,000 | 0.0% |
| Royalty Pharma PLC(RPRX) | SHS CL A | G7709Q104 | $36.4K | 750,000 | 0.0% |
| Delta AIR Lines Inc del(DAL)Call | COM NEW | 247361702 | $35.1K | 1,250,000 | 0.0% |
| Paypal Hldgs Inc(PYPL) | COM | 70450Y103 | $34.8K | 200,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $34.6K | 2,658,968 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $34.1K | 1,750,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $32.1K | 500,000 | 0.0% |
| Select Sector Spdr TR(XLI)Call | SBI INT-INDS | 81369Y704 | $30.9K | 450,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $30.1K | 1,875,000 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $28.7K | 1,600,000 | 0.0% |
| Zillow Group Inc(Z) | CL C CAP STK | 98954M200 | $27.8K | 483,000 | 0.0% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $24.5K | 250,000 | 0.0% |
| Novagold RES Inc(NG) | COM NEW | 66987E206 | $23.9K | 2,600,000 | 0.0% |
| BK of America Corp(BAC)Call | COM | 060505104 | $23.8K | 1,000,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $23.0K | 3,852,341 | 0.0% |